TMC649 / Medivir, J&J  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
TMC649 / J&J, Medivir
NCT01288677: TMC649128HPC1001 - First In-human Trial to Examine Safety, Tolerability, and Pharmacokinetics (How the Drug is Absorbed Into the Bloodstream) of Increasing Single Oral Doses of TMC649128 in Healthy Volunteers

Completed
1
54
Europe
TMC649128
Tibotec Pharmaceuticals, Ireland
Healthy Volunteer
06/11
06/11
NCT01391117: TMC649128HPC1002 - a Trial inGenotype 1 Hepatitis C Virus (HCV) - Infected Participants to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of TMC649128, Alone and Combined With Pegylated Interferon + Ribavirin

Terminated
1
14
Europe
placebo., TMC649128., placebo, TMC649128
Tibotec BVBA
Hepatitis C Virus
11/11
11/11

Download Options